Scilex Holding Company Announces That Many National Pharmacy Chains and Independent Pharmacies Have Begun Stocking GLOPERBA®
PALO ALTO, Calif., June 11, 2024 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq:SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced that many national pharmacy chains and independent pharmacy stores have begun stocking GLOPERBA®. Scilex launched GLOPERBA®, an FDA-approved prophylactic treatment for painful gout flares in adults in the U.S., on June 10, 2024.